Loading organizations...
§ Private Profile · Los Angeles, CA, USA
Superpower is a technology company.
Superpower provides a comprehensive health intelligence platform centered on personalized biomarker testing. The company offers annual comprehensive blood draws that analyze over 100 biomarkers, enabling the early detection of numerous health conditions. Utilizing AI-driven analysis, Superpower delivers individualized health plans with tailored recommendations on diet, lifestyle adjustments, and targeted supplements.
The company was co-founded in 2023 by Sergey Young and Charlie Brand. Their founding insight stemmed from a desire to create a more proactive and accessible approach to personal health management, leading to the development and launch of what they termed the world's first health super-app designed to empower individuals with actionable health data.
Superpower serves individuals seeking a detailed understanding of their physiological health and personalized strategies for improvement. Its members benefit from insights into biological age, detection of early risk factors for conditions such as diabetes and heart disease, and guidance on slowing the pace of aging. The company's vision is to establish a superior model for health that is both effective and widely accessible.
Superpower has raised $34.0M across 2 funding rounds.
Superpower has raised $34.0M in total across 2 funding rounds.
Superpower has raised $34.0M across 2 funding rounds. Most recently, it raised $30.0M Series A in April 2025.
Superpower is a Los Angeles-based health tech startup founded in 2023 that operates a digital clinic offering comprehensive biomarker testing and personalized health optimization services.[3][5] It serves individuals focused on preventive health and longevity, solving the problem of fragmented health data and reactive care by providing an all-in-one platform with over 100 biomarkers tested via partnerships like Quest Labs, biological age reports, personalized action plans, unlimited concierge support, and access to a clinic marketplace.[3][5] The company has raised $34M in Series A funding, signaling strong growth momentum in the personal health sector, with backing from investors like Forerunner Ventures, Susa Ventures, and Day One Ventures.[3]
Superpower positions itself as a "health super-app" bridging wellness and healthcare, making advanced diagnostics accessible at a fraction of concierge clinic costs (e.g., via annual memberships eligible for HSA/FSA), emphasizing early detection, prevention, and lifetime health tracking.[3][5]
Superpower was founded in 2023 in Los Angeles, California, by a team including co-founder Max Marchione, an Australian entrepreneur, amid a push to disrupt traditional healthcare models.[3] The idea emerged from recognizing gaps in preventive health: combining diagnostics, data tracking, and actionable insights into one platform to empower users with "clarity and confidence" in their health journey, contrasting reactive insurance-based care.[3][5] Early traction came swiftly with a $34M Series A round shortly after launch, led by Forerunner Ventures and including high-profile investors like Winklevoss Capital and Steve Aoki, validating its focus on biomarker-driven longevity.[3] Pivotal moments include partnerships with Quest Labs for core testing and top clinicians like Harvard MD Dr. Anant Vinjamoori as Chief Longevity Officer, accelerating development of its membership model.[5]
Superpower rides the explosive longevity and preventive health trend, fueled by rising demand for personalized medicine amid aging populations and post-pandemic health awareness.[3][5] Timing is ideal: biomarker tech and AI-driven insights are maturing, with market forces like expanding at-home testing (e.g., Quest partnerships) and investor appetite for health tech (evident in its quick $34M raise) working in its favor.[3] It influences the ecosystem by democratizing elite care—once limited to high-net-worth individuals—pushing incumbents toward prevention and fostering a data-centric model that could integrate with wearables, telehealth, and insurers for broader adoption.[5]
Superpower is poised to scale as the "world's first health super-app," expanding testing capabilities, geographic reach beyond current US states, and marketplace offerings while leveraging its clinician network for Rx integrations.[3][5] Trends like AI biomarker analysis, multimodal data (e.g., wearables + labs), and regulatory shifts toward prevention will shape its path, potentially evolving it into a full-stack longevity platform challenging Big Pharma's reactive paradigms. With $34M fuel and a prevention-first hook, Superpower could redefine personal health intelligence for millions, turning data into decades of vitality.[3][5]
Superpower has raised $34.0M in total across 2 funding rounds.
Superpower's investors include Kirsten Green, Acrew Capital, Adverb Ventures, AirAngels, AngelCube, ATX Venture Partners, Bain Capital Ventures, Canaan Partners, CP Ventures, Craft Ventures, Curie.Bio, Curious Capital.